Christopher Moreau

Christopher Moreau appears in our data through filings on Algernon Pharmaceuticals Inc. shares, published by SEDI. The record holds 35 filings, for trades running from 1 March 2018 to 27 March 2025.

The open-market record is one-sided, with 23 purchases worth €45k and not one sale. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 option exercises. In 2025 alone, the filings show 3 purchases and no sales.

Half of the purchases are above €853 and half below. The 21 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The newest entry dates from 28 March 2025: an open-market purchase of €293, in Algernon Pharmaceuticals Inc. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.